Susquehanna International Group’s Omega Therapeutics, Inc. Common Stock OMGA Stock Holding History

Susquehanna International Group’s Portfolio OMGA Stock Details OMGA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-55,322	Closed	-$88.1K	–	13278
2024 Q2	$115K	Buy	55,322 +22,102	+67%	+$52.1K	﹤0.01%	10917
2024 Q1	$121K	Sell	33,220 -33,211	-50%	-$127K	﹤0.01%	11089
2023 Q4	$200K	Buy	66,431 +268	+0.4%	+$543	﹤0.01%	10688
2023 Q3	$142K	Buy	66,163 +7,168	+12%	+$28.6K	﹤0.01%	10600
2023 Q2	$330K	Sell	58,995 -134,883	-70%	-$1.06M	﹤0.01%	9245
2023 Q1	$1.17M	Buy	193,878 +69,772	+56%	+$486K	﹤0.01%	6407
2022 Q4	$709K	Buy	124,106 +66,738	+116%	+$375K	﹤0.01%	6991
2022 Q3	$311K	Sell	57,368 -6,962	-11%	-$35.3K	﹤0.01%	9713
2022 Q2	$244K	Buy	64,330 +41,910	+187%	+$156K	﹤0.01%	10130
2022 Q1	$140K	Sell	22,420 -8,307	-27%	-$84.8K	﹤0.01%	11620
2021 Q4	$348K	Buy	+30,727	New	+$584K	﹤0.01%	10128

Other funds holding OMGA

Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Harbourvest Partners Boston, Massachusetts $101M AUM 38.13% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BOCH

Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

7IH

72 Investment Holdings Stamford, Connecticut $49.6M AUM 684.72% 1-Year Est. Return

Susquehanna International Group's OMGA Position: Q3 2024 in Review

Susquehanna International Group sold out of Omega Therapeutics, Inc. Common Stock (OMGA) in Q3 2024, closing a stake of 55,322 shares — an estimated $88.1K sold.

Susquehanna International Group first reported a position in OMGA in Q4 2021 and held it in 11 quarters. The position peaked at $1.17M in Q1 2023. 54 funds tracked by Wall St. Rank hold OMGA as of Q3 2024.

Susquehanna International Group reported no remaining Omega Therapeutics, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
Susquehanna International Group sold 55,322 Omega Therapeutics, Inc. Common Stock shares in Q3 2024, an estimated $88.1K.
Susquehanna International Group first reported a position in Omega Therapeutics, Inc. Common Stock in Q4 2021 and held it in 11 quarters.
Susquehanna International Group's Omega Therapeutics, Inc. Common Stock position peaked at $1.17M in Q1 2023.
54 funds tracked by Wall St. Rank held Omega Therapeutics, Inc. Common Stock as of Q3 2024.

Based on Susquehanna International Group's 13F filing for Q3 2024, filed 14 Nov 2024.